Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Ansell

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Haematologica|August 30, 2023
Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapyZhuoer Xie, Terra Lasho, Arushi Khurana, et al.
Blood|May 22, 2012
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experienceAnita D'Souza, Martha Lacy, Morie Gertz, et al.
Haematologica|May 2, 2016
Role of the tumor microenvironment in mature B-cell lymphoid malignanciesNathan H Fowler, Chan Yoon Cheah, Randy D Gascoyne, et al.
British Journal of Haematology|August 27, 2024
CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphomaEmil Arjun Kumar, Koorosh Korfi, Findlay Bewicke-Copley, et al.
American Journal of Hematology|June 17, 2022
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018)Karan Seegobin, Zhuo Li, Muhamad Alhaj Moustafa, et al.
Oncoimmunology|September 14, 2016
Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM WorkshopRoch Houot, Philippe Gaulard, Robert Schreiber, et al.
Blood|July 16, 2016
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapyVindi Jurinovic, Robert Kridel, Annette M Staiger, et al.
The Lancet. Oncology|July 25, 2016
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trialAnas Younes, Armando Santoro, Margaret Shipp, et al.
Transplantation and Cellular Therapy|January 1, 2026
ASTCT Clinical Practice Recommendations for Transplantation in Classical Hodgkin LymphomaSairah Ahmed, Ambuj Kumar, Paul Carpenter, et al.
American Journal of Hematology|April 15, 2025
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage TreatmentsFateeha Furqan, Kwang W Ahn, Manmeet Kaur, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Haematologica|August 30, 2023
Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapyZhuoer Xie, Terra Lasho, Arushi Khurana, et al.
Blood|May 22, 2012
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experienceAnita D'Souza, Martha Lacy, Morie Gertz, et al.
Haematologica|May 2, 2016
Role of the tumor microenvironment in mature B-cell lymphoid malignanciesNathan H Fowler, Chan Yoon Cheah, Randy D Gascoyne, et al.
British Journal of Haematology|August 27, 2024
CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphomaEmil Arjun Kumar, Koorosh Korfi, Findlay Bewicke-Copley, et al.
American Journal of Hematology|June 17, 2022
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018)Karan Seegobin, Zhuo Li, Muhamad Alhaj Moustafa, et al.
Oncoimmunology|September 14, 2016
Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM WorkshopRoch Houot, Philippe Gaulard, Robert Schreiber, et al.
Blood|July 16, 2016
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapyVindi Jurinovic, Robert Kridel, Annette M Staiger, et al.
The Lancet. Oncology|July 25, 2016
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trialAnas Younes, Armando Santoro, Margaret Shipp, et al.
Transplantation and Cellular Therapy|January 1, 2026
ASTCT Clinical Practice Recommendations for Transplantation in Classical Hodgkin LymphomaSairah Ahmed, Ambuj Kumar, Paul Carpenter, et al.
American Journal of Hematology|April 15, 2025
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage TreatmentsFateeha Furqan, Kwang W Ahn, Manmeet Kaur, et al.
Pageof 4